FDA Approves Lysteda To Treat Heavy Menstrual Bleeding

The U.S. Food and Drug Administration approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot. Heavy menstrual bleeding is reported each year by about 3 million U.S. women of reproductive age. Women with uterine fibroids may experience heavy menstrual periods.

source : www.medicalnewstoday.com

Related News:

• Carefusion Launches New Device To Help Treat Spinal Fractures
• Don’t Make That Face At Me!
• New Explanation For The Spread Of Key Protein Within The Brain, Suggesting New Ways To Diagnose And Treat Alzheimer’s
• Progesterone May Help Treat Traumatic Brain Injury Patients, Phase III Trial To Start
• Drug Used To Treat Parasites In Animals May Offer New Treatment For River Blindness, Study Finds
• SANUWAVE’s PACE Technology Is A Novel, Safe And Cost-Effective Method To Treat Severe Burns Without Surgery Or Skin Grafting
• Pluristem’s PLX Cells May Effectively Treat Ischemic StrokeBrain Research Journal Reports
• RTI Biologics Donates Matrix HD™ To Treat Young Child With Rare Genetic Skin Condition
• Physicians Must Treat Transplant Tourists
• How Evolution Can Help Doctors Understand And Treat Disease